MEDP financial statements

The full income statement, balance sheet, and cash-flow statement for Medpace Holdings Inc. (MEDP), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 31.0M2024-09 31.1M2024-12 30.5M2025-03 28.7M2025-06 28.1M2025-09 28.2M2025-12 28.4M2026-03 28.6M2026-06 27.9M-10.0% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeYoYQoQFiguresAs-reported fiscal years.

Line item	FY2025	FY2024	FY2023	FY2022	FY2021
Income Statement	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Revenue	2.53B YoY+20.0%	2.11B YoY+11.8%	1.89B YoY+29.2%	1.46B YoY+27.8%	1.14B YoY+23.4%
Selling, general & administrative	198M YoY+9.6%	180M YoY+11.7%	161M YoY+22.8%	131M YoY+21.2%	108M YoY+17.6%
Amortization of intangibles	946K YoY-34.4%	1.44M YoY-34.4%	2.20M YoY-34.4%	3.35M YoY-34.5%	5.11M YoY-35.1%
Provision for credit losses	29.0K YoY-74.3%	113K YoY-96.7%	3.42M	0.00 YoY-100.0%	11.0K YoY-93.4%
Operating income	535M YoY+19.7%	447M YoY+32.7%	337M YoY+20.9%	279M YoY+40.3%	199M YoY+18.9%
Other non-operating income	-5.34M YoY-231.6%	4.06M YoY+719.2%	-655K YoY-109.3%	7.07M YoY+111.5%	3.34M YoY+182.5%
Pre-tax income	542M YoY+14.0%	476M YoY+41.8%	336M YoY+18.7%	283M YoY+40.1%	202M YoY+19.8%
Income tax	91.3M YoY+27.6%	71.5M YoY+35.3%	52.9M YoY+41.0%	37.5M YoY+87.4%	20.0M YoY-13.6%
	451M YoY+11.6%	404M YoY+43.0%	283M YoY+15.3%	245M YoY+34.9%	182M YoY+25.1%
Net income to common	451M YoY+11.6%	404M YoY+43.1%	283M YoY+15.3%	245M YoY+35.2%	181M YoY+25.2%
	$15.28 YoY+21.0%	$12.63 YoY+42.2%	$8.88 YoY+22.0%	$7.28 YoY+51.4%	$4.81 YoY+25.3%
EPS (basic)	$15.64 YoY+19.8%	$13.06 YoY+42.0%	$9.20 YoY+21.5%	$7.57 YoY+49.6%	$5.06 YoY+24.3%
	28.8M YoY-6.8%	31.0M YoY+0.8%	30.7M YoY-5.1%	32.4M YoY-9.7%	35.9M YoY+0.6%
	29.5M YoY-7.8%	32.0M YoY+0.5%	31.8M YoY-5.4%	33.7M YoY-10.7%	37.7M YoY-0.0%
Balance Sheet	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	990M YoY-3.8%	1.03B YoY+73.3%	594M YoY+77.8%	334M YoY-51.7%	691M YoY+45.9%
Cash & equivalents	497M YoY-25.8%	669M YoY+172.7%	245M YoY+768.4%	28.3M YoY-93.9%	461M YoY+66.1%
Accounts receivable	402M YoY+35.6%	296M YoY-0.7%	298M YoY+17.8%	253M YoY+35.9%	186M YoY+15.8%
Prepaid expenses	90.5M YoY+42.9%	63.4M YoY+26.8%	50.0M YoY-4.4%	52.3M YoY+21.1%	43.2M YoY+23.6%
	1.98B YoY-6.0%	2.10B YoY+26.8%	1.66B YoY+22.5%	1.35B YoY-18.5%	1.66B YoY+19.4%
Property, plant & equipment	131M YoY+6.0%	124M YoY+2.5%	121M YoY+9.8%	110M YoY+17.9%	93.2M YoY+9.6%
Operating lease right-of-use	118M YoY-8.4%	129M YoY-11.2%	145M YoY+4.1%	139M YoY+7.3%	130M YoY+13.8%
Goodwill	662M YoY+0.0%	662M YoY+0.0%	662M YoY+0.0%	662M YoY+0.0%	662M YoY+0.0%
Intangible assets	33.4M YoY-2.8%	34.4M YoY-4.0%	35.8M YoY-5.8%	38.0M YoY-8.1%	41.4M YoY-11.0%
Deferred tax assets	19.2M YoY-80.8%	100M YoY+34.8%	74.4M YoY+54.8%	48.1M YoY+91.3%	25.1M YoY+4589.2%
Other non-current assets	21.9M YoY-1.4%	22.3M YoY-10.9%	25.0M YoY+18.2%	21.1M YoY+21.3%	17.4M YoY+98.1%
	1.34B YoY+21.7%	1.10B YoY+19.4%	925M YoY+15.1%	803M YoY+44.2%	557M YoY+26.6%
Accounts payable	28.1M YoY-13.5%	32.5M YoY+2.1%	31.9M YoY-3.6%	33.1M YoY+28.8%	25.7M YoY-3.3%
Accrued liabilities	408M YoY+32.7%	308M YoY+5.1%	293M YoY+39.4%	210M YoY+31.9%	159M YoY+18.5%
Deferred revenue	854M YoY+20.2%	711M YoY+26.9%	560M YoY+21.0%	463M YoY+34.3%	345M YoY+34.8%
Short-term & current debt	—	—	0.00 YoY-100.0%	50.0M	0.00
Current lease liability	23.2M YoY-0.3%	23.3M YoY+4.1%	22.4M YoY+16.0%	19.3M YoY+18.4%	16.3M YoY+2.4%
Other current liabilities	52.8M YoY-1.5%	53.6M YoY+32.6%	40.4M YoY-14.9%	47.5M YoY+72.2%	27.6M YoY+17.4%
	1.52B YoY+18.9%	1.28B YoY+16.2%	1.10B YoY+13.6%	966M YoY+36.6%	707M YoY+20.9%
Non-current lease liability	114M YoY-10.0%	126M YoY-11.2%	142M YoY+2.3%	139M YoY+6.0%	131M YoY+13.7%
Operating lease liability (total)	137M YoY-8.5%	150M YoY-9.1%	164M YoY+4.0%	158M YoY+7.4%	147M YoY+12.4%
Deferred tax liabilities	1.35M YoY-24.7%	1.80M YoY-25.1%	2.40M YoY+124.7%	1.07M YoY-0.9%	1.08M YoY-92.0%
Other non-current liabilities	57.7M YoY+34.9%	42.7M YoY+51.4%	28.2M YoY+24.3%	22.7M YoY+27.9%	17.7M YoY+10.3%
	459M YoY-44.4%	826M YoY+47.7%	559M YoY+44.7%	386M YoY-59.5%	953M YoY+18.3%
Preferred stock	0.00	0.00	0.00	0.00	0.00
Common stock	284K YoY-7.2%	306K YoY-0.6%	308K YoY-0.3%	309K YoY-14.2%	360K YoY+1.4%
Additional paid-in capital	936M YoY+10.9%	844M YoY+5.2%	803M YoY+4.1%	771M YoY+5.9%	728M YoY+4.6%
Retained earnings	-460M YoY-5732.2%	8.17M YoY+103.7%	-222M YoY+38.4%	-360M YoY-253.1%	235M YoY+103.9%
Treasury stock	12.2M YoY-0.6%	12.2M YoY-0.7%	12.3M YoY-1.4%	12.5M YoY+130.3%	5.43M YoY-2.7%
Accumulated other comprehensive income	-4.91M YoY+66.7%	-14.7M YoY-46.4%	-10.1M YoY+18.7%	-12.4M YoY-155.7%	-4.85M YoY-3599.2%
Total liabilities & equity	1.98B YoY-6.0%	2.10B YoY+26.8%	1.66B YoY+22.5%	1.35B YoY-18.5%	1.66B YoY+19.4%
	28.4M YoY-7.4%	30.6M YoY-0.4%	30.8M YoY-1.1%	31.1M YoY-13.7%	36.0M YoY+1.4%
	28.4M YoY-7.4%	30.6M YoY-0.4%	30.8M YoY-1.1%	31.1M YoY-13.7%	36.0M YoY+1.4%
	28.4M YoY-6.8%	30.5M YoY-1.0%	30.8M YoY-0.9%	31.1M YoY-11.9%	35.2M YoY-1.4%
Cash Flow	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	713M YoY+17.1%	609M YoY+40.5%	433M YoY+11.7%	388M YoY+47.4%	263M YoY+1.8%
Depreciation & amortization	28.1M YoY-3.9%	29.3M YoY+11.1%	26.3M YoY+17.8%	22.3M YoY+5.8%	21.1M YoY+8.1%
Intangible amortization	946K YoY-34.4%	1.44M YoY-34.4%	2.20M YoY-34.4%	3.35M YoY-34.5%	5.11M YoY-35.1%
Share-based compensation	34.8M YoY+36.3%	25.5M YoY+24.4%	20.5M YoY-4.2%	21.4M YoY+48.0%	14.5M YoY+5.0%
Deferred income taxes	80.9M YoY+403.9%	-26.6M YoY-6.6%	-25.0M YoY-8.5%	-23.0M YoY+38.0%	-37.1M YoY-7142.1%
Change in payables	2.63M YoY+188.7%	-2.96M YoY-382.1%	1.05M YoY-83.7%	6.43M YoY+244.6%	1.87M YoY+171.9%
	-31.1M YoY-10.0%	-28.3M YoY+18.3%	-34.6M YoY+10.6%	-38.7M YoY-23.5%	-31.4M YoY-0.5%
Capital expenditure	31.4M YoY-14.2%	36.5M YoY-0.3%	36.6M YoY-0.6%	36.9M YoY+30.4%	28.3M YoY-9.8%
Free cash flow	682M YoY+19.2%	572M YoY+44.2%	397M YoY+13.0%	351M YoY+49.4%	235M YoY+3.4%
Acquisitions	0.00	0.00	0.00	0.00	0.00
Other investing activities	-216K YoY+97.4%	-8.24M YoY-308.1%	-2.02M YoY-208.4%	1.86M YoY-39.8%	3.09M YoY+2554.8%
	-860M YoY-458.7%	-154M YoY+15.7%	-183M YoY+76.5%	-776M YoY-1645.2%	-44.5M YoY+46.0%
Long-term debt issued	0.00	0.00	0.00	0.00	0.00
Long-term debt repaid	0.00	0.00	0.00	0.00	0.00
Common stock issued	0.00	0.00	0.00	0.00	0.00
Common stock repurchased	917M YoY+440.1%	170M YoY+17.9%	144M YoY-83.0%	848M YoY+1265.4%	62.1M YoY-36.8%
Dividends paid	0.00	0.00	0.00	0.00	0.00
FX effect on cash	5.92M YoY+335.7%	-2.51M YoY-332.3%	1.08M YoY+116.4%	-6.57M YoY-65.5%	-3.97M YoY-696.4%
Net change in cash	-172M YoY-140.7%	424M YoY+95.2%	217M YoY+150.2%	-433M YoY-335.9%	184M YoY+25.8%
Interest paid	0.00 YoY-100.0%	171K YoY-94.4%	3.06M YoY+4.1%	2.94M YoY+2286.2%	123K YoY+18.3%
Income taxes paid	39.7M YoY-52.5%	83.6M YoY+9.4%	76.4M YoY+52.2%	50.2M YoY-10.8%	56.2M YoY+143.4%
Valuation Ratios	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Market cap	15.9B YoY+57.5%	10.1B YoY+7.6%	9.41B YoY+42.4%	6.61B YoY-13.8%	7.67B YoY+54.1%
P/E	35.3× YoY+41.2%	25.0× YoY-27.3%	34.4× YoY+18.2%	29.1× YoY-30.9%	42.2× YoY+23.2%
P/S	6.3× YoY+31.3%	4.8× YoY-9.1%	5.3× YoY+9.8%	4.8× YoY-28.4%	6.7× YoY+24.9%
P/B	34.7× YoY+183.2%	12.3× YoY-38.6%	20.0× YoY+5.8%	18.9× YoY+134.7%	8.0× YoY+30.3%
P/FCF	23.4× YoY+32.2%	17.7× YoY-29.0%	24.9× YoY+7.6%	23.1× YoY-29.1%	32.6× YoY+49.1%
	2.8% YoY-29.2%	4.0% YoY+37.5%	2.9% YoY-15.4%	3.4% YoY+44.7%	2.4% YoY-18.9%
	4.3% YoY-24.3%	5.7% YoY+40.8%	4.0% YoY-7.1%	4.3% YoY+41.0%	3.1% YoY-32.9%
Source filing	10-K	10-K	10-K	10-K	10-K

About this data

Source: MEDP's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MEDP filings on SEC EDGAR → Not investment advice.